Enhancing PET performance
within your existing infrastructure

The overlooked opportunity: timely diagnostics as a lever for successful healthcare

PET scans are increasingly central to treatment decisions across cancer, yet the time between referral and scan receives almost no attention. The evidence on treatment delays is sobering: a four-week wait can raise mortality by over 10% in some indications, and the gains from faster diagnostics may outweigh those of many costly new therapies. This piece examines why timely PET access matters, what the literature says about delay-related harm, and how expanding scanner capacity fits into a broader case for rethinking clinical infrastructure.

The capacity problem in nuclear medicine and why you should care

Demand for nuclear medicine is growing rapidly, driven by new opportunities in theranostics, neurology, and cardiology. Yet many departments struggle to keep pace, facing longer waiting lists, rising tracer costs, and increasing pressure on capacity. This whitepaper explores the cost of inaction and the clinical, operational, and financial benefits available to departments that act now.

Why AI is the missing piece in amyloid PET imaging for Alzheimer's

Anti-amyloid therapies have made PET central to Alzheimer's care, but neurodegeneration staging is still missing from most workflows. Dual-phase amyloid PET offers a fix, if the noise problem in short acquisitions can be solved. New research shows how deep learning denoising gets there.